Abeona Therapeutics Inc

Central Admixture Pharmacy Services (CAPS) is the largest network of outsourcing admixture pharmacies in the United States, providing high-quality compounded sterile preparations (CSPs) through its 21 registered 503A regional pharmacies and two FDA-registered 503B outsourcing facilities. With a focus on patient-centered care, CAPS aims to simplify operations for healthcare providers by reducing risks, costs, and resource demands associated with in-house compounding. CAPS is committed to quality assurance and compliance, implementing a comprehensive program in line with industry regulations while offering a range of sterile admixture services. Their product offerings include custom parenteral nutrition solutions, premixed Oxytocin bags, and various other specialized sterile medications designed to meet pharmaceutical needs. Generated from the website

Reese Pharmaceutical, based in Cleveland, Ohio, has been serving pharmacies for over 100 years, offering a wide range of quality branded and private label consumer health products. With a focus on innovation and customer satisfaction, Reese Pharmaceutical is a reliable and trusted vendor, providing top-notch manufacturing, packaging, and customer service in the consumer health categories. As a leader in the industry, Reese Pharmaceutical is known for its commitment to developing high-quality niche products and exceeding FDA regulations. Their flagship product, Reese's Pinworm Medicine, has been a trusted remedy for pinworm since 1986, offering affordability and effectiveness. With a diverse and satisfied customer base, Reese Pharmaceutical continues to evolve and provide new solutions to meet the needs of their customers and further enhance their brand.Generated from the website

Copernicus Therapeutics is a privately held company developing products for human gene therapy and vaccination. Copernicus was established in 1997 based on technologies discovered at Case Western Reserve University that provide the foundation for the use of DNA as drugs. The company focuses on using its technologies to make and sell gene therapy products to treat, cure or prevent human diseases. It intends to become a leading biopharmaceutical company by utilizing its DNA nanoparticle technologies to produce safe and effective DNA drugs. To maximize shareholder value, the company is using its expertise in lung gene transfer by developing products for the cystic fibrosis market. Its second therapeutic product will be for treating hemophilia B. Copernicus Therapeutics is headquartered in Cleveland.